1. Home
  2. BCDA vs TCTM Comparison

BCDA vs TCTM Comparison

Compare BCDA & TCTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCDA
  • TCTM
  • Stock Information
  • Founded
  • BCDA N/A
  • TCTM 2002
  • Country
  • BCDA United States
  • TCTM China
  • Employees
  • BCDA N/A
  • TCTM N/A
  • Industry
  • BCDA Biotechnology: Pharmaceutical Preparations
  • TCTM Other Consumer Services
  • Sector
  • BCDA Health Care
  • TCTM Real Estate
  • Exchange
  • BCDA Nasdaq
  • TCTM Nasdaq
  • Market Cap
  • BCDA 7.9M
  • TCTM 8.1M
  • IPO Year
  • BCDA N/A
  • TCTM 2014
  • Fundamental
  • Price
  • BCDA $2.73
  • TCTM $0.45
  • Analyst Decision
  • BCDA Strong Buy
  • TCTM
  • Analyst Count
  • BCDA 1
  • TCTM 0
  • Target Price
  • BCDA $25.00
  • TCTM N/A
  • AVG Volume (30 Days)
  • BCDA 59.9K
  • TCTM 43.2M
  • Earning Date
  • BCDA 03-26-2025
  • TCTM 01-01-0001
  • Dividend Yield
  • BCDA N/A
  • TCTM N/A
  • EPS Growth
  • BCDA N/A
  • TCTM N/A
  • EPS
  • BCDA N/A
  • TCTM N/A
  • Revenue
  • BCDA $71,000.00
  • TCTM $190,004,403.00
  • Revenue This Year
  • BCDA N/A
  • TCTM $99.90
  • Revenue Next Year
  • BCDA N/A
  • TCTM N/A
  • P/E Ratio
  • BCDA N/A
  • TCTM N/A
  • Revenue Growth
  • BCDA N/A
  • TCTM N/A
  • 52 Week Low
  • BCDA $1.63
  • TCTM $0.18
  • 52 Week High
  • BCDA $8.85
  • TCTM $2.99
  • Technical
  • Relative Strength Index (RSI)
  • BCDA 62.11
  • TCTM 46.55
  • Support Level
  • BCDA $2.27
  • TCTM $0.40
  • Resistance Level
  • BCDA $2.95
  • TCTM $0.69
  • Average True Range (ATR)
  • BCDA 0.26
  • TCTM 0.18
  • MACD
  • BCDA 0.04
  • TCTM 0.01
  • Stochastic Oscillator
  • BCDA 73.49
  • TCTM 23.39

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About TCTM Tarena International Inc.

TCTM Kids IT Education Inc engages in the provision of IT-focused education services in Mainland China. The company has a single reportable segment: IT-focused Supplementary STEM Education Services. It offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between three and eighteen through online teaching models and instructors from online or offline learning centers. The company also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules.

Share on Social Networks: